/GLASF
GLASF Stock - Glass House Brands Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$9.41+3.38%
+$0.31 (+3.38%) • Dec 19
89
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.95
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+27.6%upside
Target: $12.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GLASF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$9.31 – $9.50
TARGET (TP)$12.00
STOP LOSS$8.66
RISK/REWARD1:3.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.41
52W High$10.10
52W Low$3.80
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $200.90M | $160.84M | $90.89M | $69.45M | $48.26M |
| Gross Profit | $97.39M | $80.97M | $21.54M | $16.02M | $18.74M |
| Gross Margin | 48.5% | 50.3% | 23.7% | 23.1% | 38.8% |
| Operating Income | $5.74M | $-49,528,763 | $-49,898,463 | $-35,137,606 | $-6,002,950 |
| Net Income | $519,000 | $-98,270,000 | $-35,596,567 | $-44,365,586 | $-16,659,478 |
| Net Margin | 0.3% | -61.1% | -39.2% | -63.9% | -34.5% |
| EPS | $-0.21 | $-1.62 | $-0.55 | $-1.13 | $-0.78 |
Company Overview
Glass House Brands Inc. cultivates, manufactures, retails, and distributes raw cannabis, cannabis oil, and cannabis consumer goods to wholesalers and consumer packaged goods retail stores. It offers cannabis products under the Glass House Farms, Forbidden Flowers, and Mama Sue brands. Glass House Brands Inc. was founded in 2015 and is headquartered in Long Beach, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
1 Bullish0 Neutral/Bearish
Price Targets
$6
Average Target
↓ 36.2% Downside
Now
$6
Low
$6
Average
$6
High
Based on 1 analyst
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 19th 2022 | BTIG Research | Initiation | Buy | $6 |
Earnings History & Surprises
GLASFBeat Rate
38%
Last 13 quarters
Avg Surprise
-231.5%
EPS vs Estimate
Beats / Misses
5/8
Last 12 quarters
Latest EPS
$-0.15
Q4 2025
EPS Surprise History
Q1 24
-1300.0%
$-0.56vs$-0.04
Q2 24
-313.1%
$-0.54vs$-0.13
Q3 24
+120.5%
$0.08vs$-0.39
Q4 24
-1900.0%
$-0.09vs$0.01
Q1 25
+50.0%
$-0.05vs$-0.10
Q2 25
-28.6%
$-0.18vs$-0.14
Q3 25
+798.0%
$0.10vs$-0.01
Q4 25
+29.1%
$-0.15vs$-0.21
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | $-0.21 | $-0.15 | +29.1% | ✓ BEAT |
Q3 2025 | Aug 13, 2025 | $-0.01 | $0.10 | +798.0% | ✓ BEAT |
Q2 2025 | May 12, 2025 | $-0.14 | $-0.18 | -28.6% | ✗ MISS |
Q1 2025 | Mar 26, 2025 | $-0.10 | $-0.05 | +50.0% | ✓ BEAT |
Q4 2024 | Nov 13, 2024 | $0.01 | $-0.09 | -1900.0% | ✗ MISS |
Q3 2024 | Aug 13, 2024 | $-0.39 | $0.08 | +120.5% | ✓ BEAT |
Q2 2024 | May 14, 2024 | $-0.13 | $-0.54 | -313.1% | ✗ MISS |
Q1 2024 | Mar 18, 2024 | $-0.04 | $-0.56 | -1300.0% | ✗ MISS |
Q4 2023 | Nov 13, 2023 | $-0.05 | $-0.10 | -100.0% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.09 | $-0.33 | -266.7% | ✗ MISS |
Q2 2023 | May 15, 2023 | $-0.19 | $-0.57 | -200.0% | ✗ MISS |
Q1 2023 | Mar 13, 2023 | $-0.22 | $-0.26 | -18.6% | ✗ MISS |
Q4 2022 | Dec 30, 2022 | — | $-0.19 | — | — |
Q4 2022 | Nov 14, 2022 | $-0.20 | $0.04 | +120.0% | ✓ BEAT |
Q3 2022 | Aug 12, 2022 | — | $-0.24 | — | — |
Q2 2022 | May 13, 2022 | — | $-0.35 | — | — |
Q1 2022 | Mar 23, 2022 | — | $-0.30 | — | — |
Q4 2021 | Nov 11, 2021 | — | $-0.15 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.55 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GLASF
What is GLASF's current stock price?
Glass House Brands Inc. (GLASF) is currently trading at $9.41 per share. The stock has moved +3.38% today.
What is the analyst price target for GLASF?
The average analyst price target for GLASF is $12.00, based on 1 analyst.
What sector is Glass House Brands Inc. in?
Glass House Brands Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is GLASF's market cap?
Glass House Brands Inc. has a market capitalization of $0.69 billion, making it a small-cap company.
Does GLASF pay dividends?
No, Glass House Brands Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAGYTF
Allergy Therapeutics plc
$0.11
Mkt Cap: $0.5B
BOIRF
Boiron S.A.
$30.00
Mkt Cap: $0.5B
CRLBF
Cresco Labs Inc.
$1.30
Mkt Cap: $0.4B
ELTP
Elite Pharmaceuticals, Inc.
$0.49
Mkt Cap: $0.5B
HUMDF
Hua Medicine (Shanghai) Ltd.
$0.41
Mkt Cap: $0.4B
JCRRF
JCR Pharmaceuticals Co., Ltd.
$4.50
Mkt Cap: $0.5B
KHTRF
Knight Therapeutics Inc.
$4.41
Mkt Cap: $0.4B
LBLTF
Lattice Biologics Ltd.
$0.00
Mkt Cap: $0.0B
MNFSF
ManifestSeven Holdings Corporation
$0.00
Mkt Cap: $0.0B
VRNOF
Verano Holdings Corp.
$1.74
Mkt Cap: $0.6B
Explore stocks similar to GLASF for comparison